Login to Your Account



Progenics Shares Ride the Rising Tide of Relistor Sales

By Marie Powers
Staff Writer

Friday, March 15, 2013
Shares of Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) spiked Friday after the company reported that prescriptions of opioid-induced constipation (OIC) drug Relistor (methylnaltrexone bromide) increased by 90 percent in the fourth quarter of 2012 compared to the same period in 2011, growing by 137 percent for the full year compared to 2011.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription